Skip to content

Anchoring-endoscopic mucosal resection vs. endoscopic submucosal dissection

Anchoring-endoscopic mucosal resection vs. endoscopic submucosal dissection for large (20-30 mm) colorectal polyps: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008363
Enrollment
118
Registered
2023-04-17
Start date
2023-05-29
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : 1. experimental group : anchoring EMR on 20-30mm size colorectal polyp 2. active comparator group : ESD on 20-30mm size colorectal polyp In Anchoring EMR, endoscopist submucosall

Sponsors

Hallym University Medical Center-Kangnam
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients will be included in the study if they fulfill the following criteria: • Age of 19 -85 years • able to provide written informed consent • patient with 20-30 mm sized JNET IIA colorectal polyps with low possibility of submucosal invasion on narrow band imaging

Exclusion criteria

Exclusion criteria: Patients will be excluded in the study if they fulfill the following criteria: • Age of 85 years • inable to provide written informed consent • patient with confirmed malignant polyps, suspected deep invasive polyps on narrow band imaging (JENT IIB or JNET III polyp on NBI), previously incomplete resection polyps, subepithelial lesion, pedunculated polyps • Polyps in location where endoscopic procedure is difficult (located on dentate line within 3cm, IC valve, appendicile orifice polyp) • inflammatory bowel disease patients, uninterrupted antithrombotic therapy patients, coagulopathy patients

Design outcomes

Primary

MeasureTime frame
recurrence rate as determined by endoscopic assessment (no visible recurrent polyps) and histological assessment (scar biopsies) on surveillance colonoscopy

Secondary

MeasureTime frame
procedure time (measured as the time from the submucosal injection to complete removal of the polyp based on endoscopic assessment);intra-procedural and post-procedural adverse effect(delayed bleeding, immediate perforation, delayed perforation)

Countries

Korea, Republic of

Contacts

Public ContactChang Kyo Oh

Hallym University Medical Center-Kangnam

ckdryekd@gmail.com+82-2-829-5120

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026